Literature DB >> 32198754

Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State.

Monica B Pagano1,2, John R Hess1,2, Hamilton C Tsang1, Elizabeth Staley1, Terry Gernsheimer1,2, Nina Sen1, Christine Clark1, Theresa Nester3, Curt Bailey3, Kirsten Alcorn3.   

Abstract

BACKGROUND: The first coronavirus (COVID-19) case was reported in United States in the state of Washington, approximately 3 months after the outbreak in Wuhan, China. Three weeks later, the US federal government declared the pandemic a national emergency. The number of confirmed COVID-19 positive cases increased rather rapidly and changed routine daily activities of the community. STUDY DESIGN AND METHODS: This brief report describes the response from the hospital, the regional blood center, and the hospital-based transfusion services to the events that took place in the community during the initial phases of the pandemic.
RESULTS: In Washington State, the first week of March started with four confirmed cases and ended with 150; by the end of the second week of March there were more than 700 cases of confirmed COVID-19. During the first week, blood donations dropped significantly. Blood units provided from blood centers of nonaffected areas of the country helped keep inventory stable and allow for routine hospital operations. The hospital-based transfusion service began prospective triaging of blood orders to monitor and prioritize blood usage. In the second week, blood donations recovered, and the hospital postponed elective procedures to ensure staff and personal protective equipment were appropriate for the care of critical patients.
CONCLUSION: As community activities are disrupted and hospital activities switch from routine operations to pandemic focused and urgent care oriented, the blood supply and usage requires a number of transformations.
© 2020 AABB.

Entities:  

Mesh:

Year:  2020        PMID: 32198754     DOI: 10.1111/trf.15789

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  62 in total

1.  How do I… facilitate a rapid response to a public health emergency requiring plasma collection with a public-private partnership?

Authors:  Maureen J Miller; Adam Skrzekut; Ian Kracalik; Jefferson M Jones; Kathryn H Lofy; Barbara A Konkle; N Rebecca Haley; Michael Duvenhage; Tyler Bonnett; Michael Holbrook; Elizabeth Higgs; Sridhar V Basavaraju; Suman Paranjape
Journal:  Transfusion       Date:  2021-09-12       Impact factor: 3.157

2.  Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients.

Authors:  Lucas Barbosa Oliveira; Victor Irungu Mwangi; Marco Aurélio Sartim; Jeany Delafiori; Geovana Manzan Sales; Arthur Noin de Oliveira; Estela Natacha Brandt Busanello; Fernando Fonseca de Almeida E Val; Mariana Simão Xavier; Fabio Trindade Costa; Djane Clarys Baía-da-Silva; Vanderson de Souza Sampaio; Marcus Vinicius Guimarães de Lacerda; Wuelton Marcelo Monteiro; Rodrigo Ramos Catharino; Gisely Cardoso de Melo
Journal:  Front Microbiol       Date:  2022-04-27       Impact factor: 6.064

Review 3.  Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic.

Authors:  S Bennett; K Søreide; S Gholami; P Pessaux; C Teh; E Segelov; H Kennecke; H Prenen; S Myrehaug; D Callegaro; J Hallet
Journal:  Curr Oncol       Date:  2020-10-01       Impact factor: 3.677

4.  Blood usage at a large academic center in Maryland in relation to the COVID-19 pandemic in 2020.

Authors:  Colin Murphy; Magali Fontaine; Paul Luethy; Heather McGann; Bryon Jackson
Journal:  Transfusion       Date:  2021-04-26       Impact factor: 3.337

5.  Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices.

Authors:  Gopal K Patidar; Kevin J Land; Hans Vrielink; Naomi Rahimi-Levene; Eldad J Dann; Hind Al-Humaidan; Steven L Spitalnik; Yashaswi Dhiman; Cynthia So-Osman; Salwa I Hindawi
Journal:  Vox Sang       Date:  2021-03-17       Impact factor: 2.996

6.  We stand ready … Blood collection organizations and the COVID-19 pandemic.

Authors:  Hany Kamel
Journal:  Transfusion       Date:  2021-05       Impact factor: 3.157

7.  The effect of the SARS-CoV-2 pandemic and civil unrest on massive transfusion protocol activations in Minneapolis 2020.

Authors:  Alexander L Braun; Jed B Gorlin; Jessica Peters; Sherrie Murphy; Nancy L Van Buren
Journal:  Transfusion       Date:  2021-05-28       Impact factor: 3.337

8.  Apohemoglobin-haptoglobin complexes attenuate the hypertensive response to low-molecular-weight polymerized hemoglobin.

Authors:  Donald A Belcher; Carlos Munoz; Ivan S Pires; Alexander T Williams; Pedro Cabrales; Andre F Palmer
Journal:  Blood Adv       Date:  2020-06-23

9.  Management of children with glucose-6-phosphate dehydrogenase deficiency presenting with acute haemolytic crisis during the SARs-COV-2 pandemic.

Authors:  Mohsen Elalfy; Amira Adly; Khadiga Eltonbary; Islam Elghamry; Omar Elalfy; Mohamed Maebid; Khaled Elsayh; Heba-T-Allah N Elsayed; Magdy El Ekiaby
Journal:  Vox Sang       Date:  2021-06-08       Impact factor: 2.996

10.  A forecasting model to estimate the drop in blood supplies during the SARS-CoV-2 pandemic in Italy.

Authors:  Ilaria Pati; Claudio Velati; Carlo Mengoli; Massimo Franchini; Francesca Masiello; Giuseppe Marano; Eva Veropalumbo; Stefania Vaglio; Vanessa Piccinini; Simonetta Pupella; Giancarlo M Liumbruno
Journal:  Transfus Med       Date:  2021-03-10       Impact factor: 2.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.